Home › Upcoming votes › FibroBiologics, Inc.
This meeting took place on September 17, 2026. FibroBiologics, Inc. reported the official results on Form 8-K, filed September 18, 2026 (read it on EDGAR); they are listed below.
The deadline as the proxy statement states it: “vote must be received by 11:59 p.m. ET on September 16, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in FibroBiologics, Inc.’s proxy statement, with the board’s recommendation on each item. The company has filed 1 set of additional materials since; they can add to or change what is below, so check them before relying on it.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | APPROVAL OF THE JUNE 2026 STOCK ISSUANCE PROPOSAL | Board | For | — |
From FibroBiologics, Inc.’s Form 8-K, filed June 13, 2025, for the meeting held June 12, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Mathew Link | 99% | Elected |
| Elect Director: Victoria Niklas, M.D. | 96% | Elected |
| 2. Appointment by the Audit Committee of the Board of WithumSmith+Brown, PC as the Company's independent registered public accounting firm f | 99.8% | Approved |
| 3. Adoption of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the authorized capital stock | 98% | Approved |
| 4. For purposes of Nasdaq Listing Rule 5635(d), the issuance of shares of common stock to YA II PN, LTD., a Cayman Islands exempt limited co | 99.6% | Approved |
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| 1. For purposes of Nasdaq Listing Rule 5635(d), the issuance of up to 8,163,266 shares of common stock issuable upon the exercise of outstan | 92% | Approved |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.